559 related articles for article (PubMed ID: 30135326)
1. Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation.
Xu Y; Yang C; Zhang S; Li J; Xiao Q; Huang W
Biol Pharm Bull; 2018 Nov; 41(11):1638-1644. PubMed ID: 30135326
[TBL] [Abstract][Full Text] [Related]
2. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
[TBL] [Abstract][Full Text] [Related]
3. Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice.
Lebeaupin C; Vallée D; Rousseau D; Patouraux S; Bonnafous S; Adam G; Luciano F; Luci C; Anty R; Iannelli A; Marchetti S; Kroemer G; Lacas-Gervais S; Tran A; Gual P; Bailly-Maitre B
Hepatology; 2018 Aug; 68(2):515-532. PubMed ID: 29457838
[TBL] [Abstract][Full Text] [Related]
4. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
Sui YH; Luo WJ; Xu QY; Hua J
World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
[TBL] [Abstract][Full Text] [Related]
5. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
[TBL] [Abstract][Full Text] [Related]
6. Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways.
Lv Y; Gao X; Luo Y; Fan W; Shen T; Ding C; Yao M; Song S; Yan L
J Nutr Biochem; 2019 Sep; 71():110-121. PubMed ID: 31325892
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress-induced apoptosis in a streptozotocin-induced diabetes rat model.
Yu H; Zhen J; Yang Y; Gu J; Wu S; Liu Q
J Cell Mol Med; 2016 Apr; 20(4):623-31. PubMed ID: 26869403
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet.
Zhu W; Feng PP; He K; Li SW; Gong JP
Biochem Biophys Res Commun; 2018 Oct; 505(2):523-529. PubMed ID: 30269815
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg1 alleviates acute liver injury through the induction of autophagy and suppressing NF-κB/NLRP3 inflammasome signaling pathway.
Zhao J; He B; Zhang S; Huang W; Li X
Int J Med Sci; 2021; 18(6):1382-1389. PubMed ID: 33628094
[No Abstract] [Full Text] [Related]
10. Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells.
Zhou H; Liu Y; Su Y; Ji P; Kong L; Sun R; Zhang D; Xu H; Li W; Li W
J Ethnopharmacol; 2024 Apr; 324():117794. PubMed ID: 38244950
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathways.
Gao Y; Li J; Chu S; Zhang Z; Chen N; Li L; Zhang L
Eur J Pharmacol; 2020 Jan; 866():172801. PubMed ID: 31738935
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
13. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.
Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM
Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148
[TBL] [Abstract][Full Text] [Related]
14. FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury.
Han CY; Rho HS; Kim A; Kim TH; Jang K; Jun DW; Kim JW; Kim B; Kim SG
Cell Rep; 2018 Sep; 24(11):2985-2999. PubMed ID: 30208322
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
[TBL] [Abstract][Full Text] [Related]
16. [Effects of sera of rats fed with
Yang M; Chen Z; Xiao C; Tang W; Zhou B
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1277-1287. PubMed ID: 30514673
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factor.
Qi R; Jiang R; Xiao H; Wang Z; He S; Wang L; Wang Y
Life Sci; 2020 Aug; 254():117776. PubMed ID: 32437790
[TBL] [Abstract][Full Text] [Related]
19. Aqueous Extract of Pepino (
Hsu JY; Lin HH; Hsu CC; Chen BC; Chen JH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037014
[TBL] [Abstract][Full Text] [Related]
20. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]